View in EDS

Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes.

Saved in:
Bibliographic Details
Title: Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes.
Authors: Tatovic D; Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK., McAteer MA; Midatech Pharma PLC, Cardiff, UK., Barry J; Midatech Pharma PLC, Cardiff, UK., Barrientos A; Midatech Pharma PLC, Cardiff, UK., Rodríguez Terradillos K; Midatech Pharma PLC, Cardiff, UK., Perera I; Midatech Pharma PLC, Cardiff, UK., Kochba E; NanoPass Technologies Ltd., Nes Ziona, Israel., Levin Y; NanoPass Technologies Ltd., Nes Ziona, Israel., Dul M; School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK., Coulman SA; School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK., Birchall JC; School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK., von Ruhland C; Central Biotechnology Services, Cardiff University, Cardiff, UK., Howell A; Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK., Stenson R; Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK., Alhadj Ali M; Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK., Luzio SD; Diabetes Research Unit Cymru, Institute for Life Sciences, Swansea University, Swansea, UK., Dunseath G; Diabetes Research Unit Cymru, Institute for Life Sciences, Swansea University, Swansea, UK., Cheung WY; Diabetes Research Unit Cymru, Institute for Life Sciences, Swansea University, Swansea, UK., Holland G; Swansea Trials Unit, Swansea University Medical School, Swansea, UK., May K; Department of Cellular Pathology, University Hospital of Wales, Cardiff, UK., Ingram JR; Division of Infection & Immunity, Cardiff University School of Medicine, Cardiff, UK., Chowdhury MMU; Welsh Institute of Dermatology, University Hospital of Wales, Cardiff, UK., Wong FS; Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK., Casas R; Division of Pediatrics, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden., Dayan C; Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK., Ludvigsson J; Division of Pediatrics, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences and Crown Princess Victoria Children´s Hospital, Linköping University, Linköping, Sweden.
Source: Immunotherapy advances [Immunother Adv] 2022 Jan 27; Vol. 2 (1), pp. ltac002. Date of Electronic Publication: 2022 Jan 27 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101776979 Publication Model: eCollection Cited Medium: Internet ISSN: 2732-4303 (Electronic) Linking ISSN: 27324303 NLM ISO Abbreviation: Immunother Adv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35919496
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tatovic+D%22">Tatovic D</searchLink>; Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22McAteer+MA%22">McAteer MA</searchLink>; Midatech Pharma PLC, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Barry+J%22">Barry J</searchLink>; Midatech Pharma PLC, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Barrientos+A%22">Barrientos A</searchLink>; Midatech Pharma PLC, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Rodríguez+Terradillos+K%22">Rodríguez Terradillos K</searchLink>; Midatech Pharma PLC, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Perera+I%22">Perera I</searchLink>; Midatech Pharma PLC, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Kochba+E%22">Kochba E</searchLink>; NanoPass Technologies Ltd., Nes Ziona, Israel.<br /><searchLink fieldCode="AU" term="%22Levin+Y%22">Levin Y</searchLink>; NanoPass Technologies Ltd., Nes Ziona, Israel.<br /><searchLink fieldCode="AU" term="%22Dul+M%22">Dul M</searchLink>; School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Coulman+SA%22">Coulman SA</searchLink>; School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Birchall+JC%22">Birchall JC</searchLink>; School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22von+Ruhland+C%22">von Ruhland C</searchLink>; Central Biotechnology Services, Cardiff University, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Howell+A%22">Howell A</searchLink>; Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Stenson+R%22">Stenson R</searchLink>; Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Alhadj+Ali+M%22">Alhadj Ali M</searchLink>; Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Luzio+SD%22">Luzio SD</searchLink>; Diabetes Research Unit Cymru, Institute for Life Sciences, Swansea University, Swansea, UK.<br /><searchLink fieldCode="AU" term="%22Dunseath+G%22">Dunseath G</searchLink>; Diabetes Research Unit Cymru, Institute for Life Sciences, Swansea University, Swansea, UK.<br /><searchLink fieldCode="AU" term="%22Cheung+WY%22">Cheung WY</searchLink>; Diabetes Research Unit Cymru, Institute for Life Sciences, Swansea University, Swansea, UK.<br /><searchLink fieldCode="AU" term="%22Holland+G%22">Holland G</searchLink>; Swansea Trials Unit, Swansea University Medical School, Swansea, UK.<br /><searchLink fieldCode="AU" term="%22May+K%22">May K</searchLink>; Department of Cellular Pathology, University Hospital of Wales, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Ingram+JR%22">Ingram JR</searchLink>; Division of Infection & Immunity, Cardiff University School of Medicine, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Chowdhury+MMU%22">Chowdhury MMU</searchLink>; Welsh Institute of Dermatology, University Hospital of Wales, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Wong+FS%22">Wong FS</searchLink>; Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Casas+R%22">Casas R</searchLink>; Division of Pediatrics, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden.<br /><searchLink fieldCode="AU" term="%22Dayan+C%22">Dayan C</searchLink>; Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Ludvigsson+J%22">Ludvigsson J</searchLink>; Division of Pediatrics, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences and Crown Princess Victoria Children´s Hospital, Linköping University, Linköping, Sweden.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101776979%22">Immunotherapy advances</searchLink> [Immunother Adv] 2022 Jan 27; Vol. 2 (1), pp. ltac002. <i>Date of Electronic Publication: </i>2022 Jan 27 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101776979 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2732-4303 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2227324303%22">27324303 </searchLink><i>NLM ISO Abbreviation: </i>Immunother Adv <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35919496
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/immadv/ltac002
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: ltac002
    Titles:
      – TitleFull: Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tatovic D
      – PersonEntity:
          Name:
            NameFull: McAteer MA
      – PersonEntity:
          Name:
            NameFull: Barry J
      – PersonEntity:
          Name:
            NameFull: Barrientos A
      – PersonEntity:
          Name:
            NameFull: Rodríguez Terradillos K
      – PersonEntity:
          Name:
            NameFull: Perera I
      – PersonEntity:
          Name:
            NameFull: Kochba E
      – PersonEntity:
          Name:
            NameFull: Levin Y
      – PersonEntity:
          Name:
            NameFull: Dul M
      – PersonEntity:
          Name:
            NameFull: Coulman SA
      – PersonEntity:
          Name:
            NameFull: Birchall JC
      – PersonEntity:
          Name:
            NameFull: von Ruhland C
      – PersonEntity:
          Name:
            NameFull: Howell A
      – PersonEntity:
          Name:
            NameFull: Stenson R
      – PersonEntity:
          Name:
            NameFull: Alhadj Ali M
      – PersonEntity:
          Name:
            NameFull: Luzio SD
      – PersonEntity:
          Name:
            NameFull: Dunseath G
      – PersonEntity:
          Name:
            NameFull: Cheung WY
      – PersonEntity:
          Name:
            NameFull: Holland G
      – PersonEntity:
          Name:
            NameFull: May K
      – PersonEntity:
          Name:
            NameFull: Ingram JR
      – PersonEntity:
          Name:
            NameFull: Chowdhury MMU
      – PersonEntity:
          Name:
            NameFull: Wong FS
      – PersonEntity:
          Name:
            NameFull: Casas R
      – PersonEntity:
          Name:
            NameFull: Dayan C
      – PersonEntity:
          Name:
            NameFull: Ludvigsson J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 01
              Text: 2022 Jan 27
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2732-4303
          Numbering:
            – Type: volume
              Value: 2
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Immunotherapy advances
              Type: main
ResultId 1